Figure 1.
Figure 1. Characterization of T-cell clones generated from CD4+CD25+, CD8+CD25+, CD4+CD25- thymocyte suspensions. (A) T-cell clones generated from purified CD4+CD25+ or CD8+CD25+ thymocytes were assessed for their ability to inhibit the proliferative response of CD4+CD25- autologous thymocytes to allogeneic stimulation, as described in “Materials and methods.” Results are expressed as mean percentage of inhibition of proliferation obtained in triplicate cultures of each CD4+ or CD8+ T-cell clone. (B) T-cell clones generated from CD4+CD25+, CD8+CD25+, CD4+CD25- thymocytes were assessed for their ability to produce IL-4 and/or IFN-γ by flow cytometry analysis at single cell level. Production of cytokines by each clone was considered as noteworthy when the proportion of producer T-cell blasts was higher than 10%.

Characterization of T-cell clones generated from CD4+CD25+, CD8+CD25+, CD4+CD25- thymocyte suspensions. (A) T-cell clones generated from purified CD4+CD25+ or CD8+CD25+ thymocytes were assessed for their ability to inhibit the proliferative response of CD4+CD25- autologous thymocytes to allogeneic stimulation, as described in “Materials and methods.” Results are expressed as mean percentage of inhibition of proliferation obtained in triplicate cultures of each CD4+ or CD8+ T-cell clone. (B) T-cell clones generated from CD4+CD25+, CD8+CD25+, CD4+CD25- thymocytes were assessed for their ability to produce IL-4 and/or IFN-γ by flow cytometry analysis at single cell level. Production of cytokines by each clone was considered as noteworthy when the proportion of producer T-cell blasts was higher than 10%.

Close Modal

or Create an Account

Close Modal
Close Modal